Juan Manuel Santa Maria

145 Added | 1 Magazine | 1 Like | 6 Following | 4 Followers | @Jsantamaria01 | Keep up with Juan Manuel Santa Maria on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Juan Manuel Santa Maria”

AbbVie buys Pharmacyclics for $21bn

AbbVie is adding substantial ballast to its pipeline through a deal to buy Pharmacyclics for a whopping $21 billion.<p>The moves gives AbbVie access to …

Landmark approval for Novartis' Zarxio as first US biosimilar

Novartis white blood cell-stimulater Zarxio (filgrastim-sndz) has become the first biosimilar to be allowed entry to the US market, paving the way …

LAS DROGUERIAS Y LAS FARMACIAS ARRASTRADAS POR LOS ATRASOS DEL PAMI

<b>Muchas droguerías han comenzado a cortar la provisión de medicamentos a las farmacías debido a la falta de pago que se origina en la deuda del PAMI</b> …

PATENTES: VUELVEN LOS ESCENARIOS CONFLICTIVOS COMO EN LOS '90

<b>La organización Mundial de Propiedad Intelectual (OMPI) volvió a convertirse en el campo de batalla contra las patentes farmacéuticas que obstruyan</b> …

PRIMERA JORNADA FARMOQUIMICA ARGENTINA

En un marco de gran cantidad de asistentes, se realizó la Primera Jornada Farmoquímica Argentina, organizada por la Cámara Argentina de Productores …

LOS BIOSIMILARES YA EXISTEN Y EL PRIMERO FUE APROBADO POR CHIALE

<b>Uno de los argumentos para desplazar a Carlos Chiale de la ANMAT fue que el organismo demoraba en demasía en aprobar los biosimilares. La demora</b> …

GENERICOS Y PRODUCCION PUBLICA EN LA AGENDA DEL MINISTRO GOLLAN

<b>La prescripción por genéricos y la producción pública de medicamentos figuran entre las prioridades del nuevo ministro de Salud, Daniel Gollan, quien</b> …

The top 10 pharma companies in social media | FiercePharma

Chatting with the public is not in pharma's comfort zone. Drugmakers are adept at the one-way communication known as direct-to-consumer advertising, …

10 big brands keep pumping out big bucks, with a little help from price hikes | FiercePharma

Drugmakers raise U.S. prices to make more money. This isn't a surprise to anyone. It's a basic business strategy, and the U.S. market is among the …

The top 10 most expensive drugs of 2013

The price of Gilead Sciences' breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, …

Biotechnology

LOS GENERICOS Y LOS PRECIOS EN LA AGENDA POLITICA DEL 2015

<b>El Acta Acuerdo firmado en la Plata en apoyo a la prescripción por el nombre genérico y la sanción parlamentaria de la Agencia Nacional de</b> …

Shire to buy NPS in $5.2 billion deal

After months of rumours, Shire is buying fellow rare disease specialist NPS Pharmaceuticals in a transaction worth $5.2 billion.<p>The Ireland-domiciled …

Can failed Roche drug be first personalised heart med?

Scientists in Canada are claiming a world first, saying that dalcetrapib, a cholesterol drug scrapped by Roche nearly three years ago, could in fact …

Pharma and docs up in arms over Cancer Drugs Fund cuts

The list of drugs to be cut from the Cancer Drugs Fund has yet to be confirmed but drugmakers and doctors have already gone public with their …

Doctors Question Wider Hepatitis C Screening Despite New Cures

• Study data published in the BMJ question the expansion of widespread screening for hepatitis C despite the availability if newer, potentially …

The big-data revolution in US health care: Accelerating value and innovation

Big data could transform the health-care sector, but the industry must undergo fundamental changes before stakeholders can capture its full value.<p><b>A</b> …

Health Care

Applying lean IT to healthcare

Lean IT can help providers in their quest to create a digital enterprise.<p><b>The healthcare sector</b> is going through fundamental technology-enabled …

Shire, seeking to expand, buys NPS for $5.2 billion

SAN FRANCISCO — The surge of biopharma mergers that dominated 2014 continued into the new year, with Shire PLC and Biogen Idec Inc. unveiling …

Gilead's hepatitis C drug Harvoni selected by health insurer Anthem

Gilead Sciences reached a deal with Anthem under which the drugmaker's therapy Harvoni (ledipasvir/sofosbuvir) will be offered as the primary option …